Hsieh Ming forfeited 4,392 Fulgent Genetics shares at $19.59 per share on Sep. 1, 2026, under SEC transaction code F. The chief executive owned 885,952 shares afterward, giving investors the reported post-transaction ownership figure for the insider transaction.
Key Highlights
- Hsieh Ming is identified as Fulgent Genetics’ chief executive officer.
- The transaction was recorded at $19.59 per share.
- Hsieh Ming’s reported ownership after the transaction was 885,952 shares.
Hsieh Ming forfeited 4,392 shares of Fulgent Genetics (NASDAQ: FLGT). The transaction involved Fulgent Genetics Equity and was recorded as an insider transaction.
Fulgent Genetics Insider Transaction Details
The filing lists the forfeiture at $19.59 per share. Hsieh Ming’s reported ownership following the event stood at 885,952 shares of Fulgent Genetics. The transaction was reported through a Form 4 insider-transaction record. The record reports Hsieh Ming’s forfeiture of Fulgent Genetics shares. The reported post-transaction figure covers the shares owned after the forfeiture.
FAQs
Q: How many Fulgent Genetics shares did Hsieh Ming forfeit?
A: Hsieh Ming forfeited 4,392 shares of Fulgent Genetics on September 1, 2026, according to the Form 4. The filing lists the transaction under SEC code F.
Q: What price was listed for the forfeited shares?
A: The filing lists the forfeiture at $19.59 per share. It identifies Hsieh Ming as Fulgent Genetics’ chief executive officer in the transaction record.
Q: How many Fulgent Genetics shares did Hsieh Ming own afterward?
A: Following the transaction, Hsieh Ming owned 885,952 shares of Fulgent Genetics. The Form 4 reports this figure as the company shares owned after the transaction.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.